Xconomy | San Diego - Business + Technology in the Exponential Economy

Related Posts

Life Sciences, people, obesity

Orexigen Names New CEO

Juha-Pekka Tikka 3/31/09

San Diego-based Orexigen Therapeutics (NASDAQ: OREX) today named Michael Narachi as President and CEO. Narachi, 50, has spent the past 24 years in the biopharmaceutical business, and previously served as CEO of Ren Pharmaceuticals in South San Francisco, CA. The company is developing a treatment for obesity. Orexigen reported in January that a late-stage clinical trial of a  drug met its goal of helping patients lose weight, but the results disappointed Wall Street.

Comments | Reprints | Share:   Retweet Facebook Email

Add Your Thoughts



You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted. By clicking "Publish," you are agreeing to these Terms and Conditions.

    
Xconomy network map Seattle Boston San Diego
national life-sciences startups

Most Popular Stories

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.